VDYNE Launch Global Feasibility Study and Designated as a Breakthrough Device
Press Release Jean Boulle Group’s VDYNE Heart Valve Technology International Feasibility Study and Breakthrough Device Designation from the FDA. Luxembourg 26 April 2023 The Jean Boulle Group is pleased to note the announcement by its medtech device company VDYNE regarding the launch of its global feasibility study for the pioneering Transcatheter Tricuspid Valve in twenty…